ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,136.99
0.42%
Dow Jones
43,325.80
0.07%
Gold vs US Dollar
2,634.43
0.06%
Brent Oil
72.915
0.03%
Bitcoin
96,436.07
0.78%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. USOTC
  6. Bionik Laboratories Corporation (CE) (BNKL)

  7. Bionik Laboratories Corporation (CE) (BNKL) News

Bionik Laboratories (CE) (BNKL)

Bionik Laboratories Corporation (CE)
Date:
Sort by:
 Showing the most relevant articles for your search:USOTC:BNKL
DateTimeSourceHeadlineSymbolCompany
30/06/202320:31Edgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]USOTC:BNKLBionik Laboratories Corporation (CE)
21/06/202321:05Edgar (US Regulatory)Annual Report (10-k)USOTC:BNKLBionik Laboratories Corporation (CE)
21/06/202314:59Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:BNKLBionik Laboratories Corporation (CE)
21/06/202314:58Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:BNKLBionik Laboratories Corporation (CE)
21/06/202314:58Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:BNKLBionik Laboratories Corporation (CE)
21/06/202314:56Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:BNKLBionik Laboratories Corporation (CE)
16/06/202312:56Edgar (US Regulatory)Current Report Filing (8-k)USOTC:BNKLBionik Laboratories Corporation (CE)
15/06/202317:10Edgar (US Regulatory)Current Report Filing (8-k)USOTC:BNKLBionik Laboratories Corporation (CE)
04/05/202321:25Edgar (US Regulatory)Current Report Filing (8-k)USOTC:BNKLBionik Laboratories Corporation (CE)
26/04/202320:31Edgar (US Regulatory)Current Report Filing (8-k)USOTC:BNKLBionik Laboratories Corporation (CE)
23/02/202321:08Edgar (US Regulatory)Current Report Filing (8-k)USOTC:BNKLBionik Laboratories Corporation (CE)
08/02/202321:21Edgar (US Regulatory)Current Report Filing (8-k)USOTC:BNKLBionik Laboratories Corporation (CE)
08/02/202313:02Edgar (US Regulatory)Quarterly Report (10-q)USOTC:BNKLBionik Laboratories Corporation (CE)
20/01/202321:32Edgar (US Regulatory)Current Report Filing (8-k)USOTC:BNKLBionik Laboratories Corporation (CE)
07/12/202216:29Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)USOTC:BNKLBionik Laboratories Corporation (CE)
07/12/202216:27Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)USOTC:BNKLBionik Laboratories Corporation (CE)
17/11/202222:26Edgar (US Regulatory)Current Report Filing (8-k)USOTC:BNKLBionik Laboratories Corporation (CE)
09/11/202213:01Edgar (US Regulatory)Quarterly Report (10-q)USOTC:BNKLBionik Laboratories Corporation (CE)
09/11/202212:31Edgar (US Regulatory)Current Report Filing (8-k)USOTC:BNKLBionik Laboratories Corporation (CE)
07/11/202213:02Edgar (US Regulatory)Current Report Filing (8-k)USOTC:BNKLBionik Laboratories Corporation (CE)
04/11/202220:32Edgar (US Regulatory)Amended Current Report Filing (8-k/a)USOTC:BNKLBionik Laboratories Corporation (CE)
25/10/202215:28Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)USOTC:BNKLBionik Laboratories Corporation (CE)
13/10/202217:18Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:BNKLBionik Laboratories Corporation (CE)
13/10/202212:01Edgar (US Regulatory)Current Report Filing (8-k)USOTC:BNKLBionik Laboratories Corporation (CE)
08/09/202211:32Edgar (US Regulatory)Current Report Filing (8-k)USOTC:BNKLBionik Laboratories Corporation (CE)
01/09/202211:31Edgar (US Regulatory)Current Report Filing (8-k)USOTC:BNKLBionik Laboratories Corporation (CE)
31/08/202220:31Edgar (US Regulatory)Current Report Filing (8-k)USOTC:BNKLBionik Laboratories Corporation (CE)
16/08/202211:35Edgar (US Regulatory)Current Report Filing (8-k)USOTC:BNKLBionik Laboratories Corporation (CE)
10/08/202212:03Edgar (US Regulatory)Quarterly Report (10-q)USOTC:BNKLBionik Laboratories Corporation (CE)
10/08/202211:31Edgar (US Regulatory)Current Report Filing (8-k)USOTC:BNKLBionik Laboratories Corporation (CE)
 Showing the most relevant articles for your search:USOTC:BNKL

Your Recent History

LSE
BP.
Bp
LSE
TW.
Taylor Wimpey
LSE
FIH
Fih
LSE
SRSP
Sirius Petroleum
LSE
FGEN
Foresight Environmental ...
LSE
GGP
Greatland Gold
LSE
CPX
Cap-xx
NASDAQ
RGTI
Rigetti Computing
LSE
SCLP
Scancell
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved

    Go Ad-Free

    Subscribe to Ad free and enjoy an ad-free experience

    No Ads

    Try Now

    Keep the Ads